• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 HYPERFORM; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 HYPERFORM; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY Back to Search Results
Model Number 104-4470
Device Problems Burst Container or Vessel (1074); Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/08/2021
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information reporting that during preparation, the physician found that the hyperform balloon was leaking contrast.The balloon was replaced with a competitor's device for the procedure.As the issue occurred during preparation, there was no harm to the patient.
 
Event Description
No additional information received.
 
Manufacturer Narrative
H3: analysis of the hyperform occlusion balloon catheter and guidewire (lot no.A765161) found no bends or kinks with the pushwire of the hyperform guidewire.A dried residue (likely saline) was found on the hyperform guidewire proximal solder region.The hyperglide guidewire distal tip was found to be bent.The hyperform guidewire distal od (outer diameter) was measured to be 0.00970¿ which is within specification (specification: 0.0103¿ max).Due to its damaged condition, the hyperform guidewire could not be used with the returned hyperform occlusion balloon catheter.The hyperform occlusion balloon catheter was then examined.Upon visual inspection, no issues or irregularities were found with the hyperform occlusion balloon catheter hub.No bends or kinks were found with the hyperform catheter body.The hyperform occlusion balloon catheter was flushed, water exited from the distal tip.In order to test for balloon inflation, a mandrel was inserted into the distal tip of the balloon for the leak test.The balloon was successfully inflated and deflated without issue.No leaks were detected.No other anomalies were observed.Based on the device analysis and reported information, the customer¿s report of ¿balloon leak at distal guidewire seal¿ could not be confirmed.It is possible that damage to the guidewire may have contributed to the reported event; however, the cause could not be determined.H6: method code updated to b01.Result code updated to c070601.Conclusion code updated to d15.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received and it was reported the balloon leak was in the proximal area.The balloon was inflated and deflated two times.The injection rate was slow.A 1 mi syringe was used during inflation and deflation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYPERFORM
Type of Device
CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
MDR Report Key11314158
MDR Text Key231403416
Report Number2029214-2021-00169
Device Sequence Number1
Product Code MJN
Combination Product (y/n)N
PMA/PMN Number
K091458
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 10/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/05/2021
Device Model Number104-4470
Device Catalogue Number104-4470
Device Lot NumberA765161
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/02/2021
Initial Date Manufacturer Received 02/08/2021
Initial Date FDA Received02/11/2021
Supplement Dates Manufacturer Received05/05/2021
10/01/2021
Supplement Dates FDA Received05/20/2021
10/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-